On July 18, 2026, the European Food Safety Authority (EFSA) released an updated framework for the risk assessment of natural antioxidants used as food additives, triggering mandatory re-evaluation for 12 categories including rosemary extract (E392), ascorbyl palmitate (E304a), and tea polyphenols (E306). With a new compliance requirement set to apply from October 1, 2026, the development deserves close attention from Chinese food ingredient exporters, regulatory teams, import documentation managers, and downstream buyers because it directly affects filing routes linked to CPNP and Novel Food submissions, as well as the cost and preparation of supporting test data.

What EFSA has formally updated

According to the information provided, EFSA issued the document Natural Antioxidants: Updated Risk Assessment Framework for Food Additives (Q-2026-07-003) on July 18, 2026. The update starts a mandatory re-evaluation process for 12 types of natural antioxidants, including rosemary extract (E392), ascorbyl palmitate (E304a), and tea polyphenols (E306).

The same update requires all imported products covered by the new framework to include an EFSA-recognized toxicology data package from October 1, 2026. The required package includes NOAEL, BMD2.5, and a metabolic stability report. The information provided also states that this change directly affects the CPNP and Novel Food filing path for Chinese food ingredient exporters to the European Union, while also increasing testing-related costs.

Where the pressure is likely to appear first

Exporters handling regulated ingredient submissions

From an industry perspective, Chinese exporters shipping natural antioxidant ingredients into the EU may be affected first because the update is tied directly to import compliance documentation. The immediate pressure point is the submission package itself: products that previously relied on existing supporting materials may now need a newly recognized toxicology file before filing or market entry can proceed under the updated expectation.

Manufacturers using affected antioxidants in formulations

Processing and manufacturing businesses that use the listed antioxidants in export-oriented formulations may also face operational impact. Analysis shows the issue is not limited to a single additive name; it reaches the formulation stage, ingredient selection stage, and document handover stage, especially where products depend on rosemary extract, ascorbyl palmitate, tea polyphenols, or other antioxidants included in the 12-category review.

Import compliance and documentation service providers

Service providers managing dossiers, regulatory submissions, and technical files may see a heavier workload because the update changes both the expected data structure and the supporting evidence threshold. What deserves closer attention is the connection between toxicology data requirements and filing pathways, since this can affect review timelines, document completeness checks, and communication between exporters and EU-side partners.

Downstream buyers and sourcing teams

Buyers sourcing affected ingredients for EU-bound products may need to pay closer attention to supplier readiness. Observably, the key issue is not only whether an ingredient is available, but whether the supplier can provide EFSA-recognized data in time for orders, customer reviews, and shipment planning after October 1, 2026.

What companies should track now

Whether existing dossiers can still support ongoing business

Analysis shows one practical question stands out: whether current technical files and submission materials remain usable under the updated EFSA framework. Companies involved in CPNP or Novel Food-related preparation should check whether existing toxicology support already covers the newly specified elements or whether additional work will be needed.

The gap between a policy release and filing execution

What deserves closer attention is the difference between the publication of the framework and the way it is applied in actual submissions from October 1, 2026. Businesses should treat the rule text and the operational filing process as related but not identical issues, especially where document acceptance standards, review interpretation, or timing of supplementary materials could affect delivery schedules.

Testing budgets and supplier document readiness

The information provided already indicates that testing costs will be affected. For companies purchasing or exporting the covered antioxidants, the practical focus should be on whether suppliers can produce NOAEL, BMD2.5, and metabolic stability materials in a format that aligns with EFSA recognition expectations, and whether added testing time could influence order cycles or customer commitments.

Customer communication around affected categories

For businesses already serving EU accounts, it is reasonable to prepare category-specific communication around the antioxidants named in the update and any other products within the 12-category scope. This is less about broad messaging and more about clarifying submission status, document availability, and possible timing implications for regulated exports.

How this development is best understood at this stage

Observation suggests this is more than a routine wording update because it introduces a concrete compliance deadline and identifies specific toxicology components that will be required for imported products. At the same time, it is more appropriate to understand this as a regulatory signal that is already entering implementation, rather than as a fully settled market outcome. The confirmed facts establish a new documentation threshold, but the full commercial effect will still depend on how quickly exporters, suppliers, and filing teams can adapt their materials and workflows.

From an industry perspective, the most important point is that the impact is concentrated in compliance execution, technical evidence preparation, and filing cost. That makes this a near-term operational issue as well as a longer-term signal about how natural additives may be scrutinized in the EU going forward.

Why this matters beyond the announcement itself

In practical terms, the EFSA update matters because it links product access more closely to data quality and data format for a defined group of natural antioxidants. For Chinese food ingredient exporters, this should currently be understood as an actionable compliance development rather than a distant policy discussion. The rule change has a clear date, a defined documentation expectation, and a direct connection to filing pathways and testing expense, but its broader market consequences still require continued observation.

Basis of this report and what still needs verification

This article is based on the user-provided news title, event date, and event summary. For this type of industry update, commonly relevant source categories may include official notices, company statements, industry association updates, authoritative media coverage, and standards or regulatory documents. The specific official source link was not provided in the input, so the underlying document trail and any later interpretive updates still need to be continuously verified. Follow-up attention should focus on any further official clarification regarding implementation details, filing practice, and the practical treatment of the required toxicology package.